Hypersensitivity reactions
This anti-IL-1 agent is normally well tolerated and indicated as an
alternative in cases with an anaphylactic reaction to anakinra
(135).
However, there is a recently reported case who developed immediate
diffuse urticaria after the tenth canakinumab administration and was
prevented from further reactions with cetirizine premedication
(134).